Strata Critical Medical (SRTA) Competitors

$5.32 -0.05 (-0.93%)

As of 09/4/2026 04:00 PM Eastern

SRTA vs. ASTH, PGNY, GRDN, AGL, and INNV

Should you buy Strata Critical Medical stock or one of its competitors? Strata Critical Medical's main competitors and comparable companies include Astrana Health (ASTH), Progyny (PGNY), Guardian Pharmacy Services (GRDN), Agilon Health (AGL), and InnovAge (INNV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Strata Critical Medical compare to Astrana Health?

Astrana Health (NASDAQ:ASTH) and Strata Critical Medical (NASDAQ:SRTA) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Astrana Health has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.26, meaning that its share price is 126% more volatile than the broader market.

Astrana Health currently has a consensus price target of $49.43, suggesting a potential upside of 28.49%. Strata Critical Medical has a consensus price target of $8.00, suggesting a potential upside of 50.38%. Given Strata Critical Medical's higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Strata Critical Medical has lower revenue, but higher earnings than Astrana Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.67	$22.49M	$0.82	46.91
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A

In the previous week, Astrana Health had 4 more articles in the media than Strata Critical Medical. MarketBeat recorded 4 mentions for Astrana Health and 0 mentions for Strata Critical Medical. Astrana Health's average media sentiment score of 1.39 beat Strata Critical Medical's score of 0.00 indicating that Astrana Health is being referred to more favorably in the media.

Company	Overall Sentiment
Astrana Health	Positive
Strata Critical Medical	Neutral

Strata Critical Medical has a net margin of 15.71% compared to Astrana Health's net margin of 1.05%. Astrana Health's return on equity of 10.30% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
Strata Critical Medical	15.71%	-2.97%	-2.54%

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Astrana Health beats Strata Critical Medical on 11 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Progyny?

Strata Critical Medical (NASDAQ:SRTA) and Progyny (NASDAQ:PGNY) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Strata Critical Medical has a beta of 2.26, meaning that its stock price is 126% more volatile than the broader market. Comparatively, Progyny has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Progyny has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
Progyny	$1.31B	1.52	$58.52M	$0.92	28.20

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 9.9% of Progyny shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Progyny had 9 more articles in the media than Strata Critical Medical. MarketBeat recorded 9 mentions for Progyny and 0 mentions for Strata Critical Medical. Progyny's average media sentiment score of 1.34 beat Strata Critical Medical's score of 0.00 indicating that Progyny is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
Progyny	Positive

Strata Critical Medical presently has a consensus price target of $8.00, suggesting a potential upside of 50.38%. Progyny has a consensus price target of $33.91, suggesting a potential upside of 30.72%. Given Strata Critical Medical's higher probable upside, research analysts plainly believe Strata Critical Medical is more favorable than Progyny.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Progyny	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.85

Strata Critical Medical has a net margin of 15.71% compared to Progyny's net margin of 6.00%. Progyny's return on equity of 15.98% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
Progyny	6.00%	15.98%	10.65%

Summary

Progyny beats Strata Critical Medical on 11 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Strata Critical Medical (NASDAQ:SRTA) and Guardian Pharmacy Services (NYSE:GRDN) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

47.4% of Strata Critical Medical shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Strata Critical Medical currently has a consensus target price of $8.00, indicating a potential upside of 50.38%. Guardian Pharmacy Services has a consensus target price of $43.83, indicating a potential upside of 7.17%. Given Strata Critical Medical's higher possible upside, equities analysts plainly believe Strata Critical Medical is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Guardian Pharmacy Services has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
Guardian Pharmacy Services	$1.46B	1.39	$49.22M	$1.03	39.71

In the previous week, Guardian Pharmacy Services had 6 more articles in the media than Strata Critical Medical. MarketBeat recorded 6 mentions for Guardian Pharmacy Services and 0 mentions for Strata Critical Medical. Guardian Pharmacy Services' average media sentiment score of 0.89 beat Strata Critical Medical's score of 0.00 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
Guardian Pharmacy Services	Positive

Strata Critical Medical has a net margin of 15.71% compared to Guardian Pharmacy Services' net margin of 4.50%. Guardian Pharmacy Services' return on equity of 29.97% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Strata Critical Medical has a beta of 2.26, suggesting that its share price is 126% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.06, suggesting that its share price is 94% less volatile than the broader market.

Summary

Guardian Pharmacy Services beats Strata Critical Medical on 11 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Agilon Health?

Agilon Health (NYSE:AGL) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

Strata Critical Medical has lower revenue, but higher earnings than Agilon Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.92B	0.25	-$391.35M	-$14.27	N/A
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A

Agilon Health currently has a consensus price target of $97.70, indicating a potential upside of 10.92%. Strata Critical Medical has a consensus price target of $8.00, indicating a potential upside of 50.38%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts clearly believe Strata Critical Medical is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.21
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Strata Critical Medical has a net margin of 15.71% compared to Agilon Health's net margin of -3.92%. Strata Critical Medical's return on equity of -2.97% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
Strata Critical Medical	15.71%	-2.97%	-2.54%

Agilon Health has a beta of 3.02, suggesting that its share price is 202% more volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.26, suggesting that its share price is 126% more volatile than the broader market.

47.4% of Strata Critical Medical shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Agilon Health had 3 more articles in the media than Strata Critical Medical. MarketBeat recorded 3 mentions for Agilon Health and 0 mentions for Strata Critical Medical. Agilon Health's average media sentiment score of 0.34 beat Strata Critical Medical's score of 0.00 indicating that Agilon Health is being referred to more favorably in the media.

Company	Overall Sentiment
Agilon Health	Neutral
Strata Critical Medical	Neutral

Summary

Strata Critical Medical beats Agilon Health on 11 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to InnovAge?

Strata Critical Medical (NASDAQ:SRTA) and InnovAge (NASDAQ:INNV) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

In the previous week, InnovAge had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 2 mentions for InnovAge and 0 mentions for Strata Critical Medical. InnovAge's average media sentiment score of 0.89 beat Strata Critical Medical's score of 0.00 indicating that InnovAge is being referred to more favorably in the news media.

Company	Overall Sentiment
Strata Critical Medical	Neutral
InnovAge	Positive

Strata Critical Medical has a net margin of 15.71% compared to InnovAge's net margin of -1.22%. Strata Critical Medical's return on equity of -2.97% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
InnovAge	-1.22%	-4.73%	-2.20%

Strata Critical Medical has a beta of 2.26, indicating that its share price is 126% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

Strata Critical Medical currently has a consensus target price of $8.00, indicating a potential upside of 50.38%. InnovAge has a consensus target price of $10.00, indicating a potential downside of 6.98%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts plainly believe Strata Critical Medical is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Comparatively, 1.0% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Strata Critical Medical has higher earnings, but lower revenue than InnovAge. Strata Critical Medical is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.39	$41.35M	-$0.04	N/A
InnovAge	$949.17M	1.54	-$30.31M	-$0.09	N/A

Summary

Strata Critical Medical beats InnovAge on 11 of the 16 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTA vs. The Competition

Export

Metric	Strata Critical Medical	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$475.07M	$10.10B	$7.26B	$12.90B
Dividend Yield	N/A	2.59%	2.53%	8.90%
P/E Ratio	-133.00	34.60	273.83	25.45
Price / Sales	2.39	4.85	608.03	79.09
Price / Cash	N/A	121.75	77.39	52.28
Price / Book	1.68	3.99	12.85	6.17
Net Income	$41.35M	$313.25M	$3.49B	$350.08M
7 Day Performance	-10.89%	1.06%	1.04%	-0.14%
1 Month Performance	-9.06%	0.33%	5.52%	1.02%
1 Year Performance	N/A	15.31%	24.39%	14.51%

Strata Critical Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTA Strata Critical Medical	1.992 of 5 stars	$5.32 -0.9%	$8.00 +50.4%	N/A	$475.07M	$197.14M	N/A	130	Positive News
ASTH Astrana Health	4.1099 of 5 stars	$38.61 +2.7%	$49.43 +28.0%	+24.8%	$2.15B	$3.84B	47.09	3,000	News Coverage Positive News
PGNY Progyny	4.2725 of 5 stars	$26.37 +2.1%	$33.91 +28.6%	+10.1%	$2.02B	$1.29B	28.66	310	Positive News Analyst Forecast
GRDN Guardian Pharmacy Services	2.5694 of 5 stars	$37.56 +0.7%	$43.83 +16.7%	+43.6%	$1.87B	$1.45B	36.47	3,600
AGL Agilon Health	1.5799 of 5 stars	$95.19 -1.0%	$97.70 +2.6%	+190.0%	$1.60B	$5.93B	N/A	1,076

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTA) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Critical Medical (SRTA) Competitors

SRTA vs. ASTH, PGNY, GRDN, AGL, and INNV

How does Strata Critical Medical compare to Astrana Health?

Summary

How does Strata Critical Medical compare to Progyny?

Summary

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Summary

How does Strata Critical Medical compare to Agilon Health?

Summary

How does Strata Critical Medical compare to InnovAge?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Critical Medical (SRTA) Competitors

SRTA vs. ASTH, PGNY, GRDN, AGL, and INNV

How does Strata Critical Medical compare to Astrana Health?

Which has more volatility & risk, ASTH or SRTA?

Do analysts prefer ASTH or SRTA?

Which has better earnings and valuation, ASTH or SRTA?

Does the media prefer ASTH or SRTA?

Is ASTH or SRTA more profitable?

Do insiders and institutionals have more ownership in ASTH or SRTA?

Summary

How does Strata Critical Medical compare to Progyny?

Which has more volatility & risk, SRTA or PGNY?

Which has stronger valuation and earnings, SRTA or PGNY?

Do institutionals and insiders hold more shares of SRTA or PGNY?

Does the media favor SRTA or PGNY?

Do analysts recommend SRTA or PGNY?

Is SRTA or PGNY more profitable?

Summary

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Do insiders and institutionals hold more shares of SRTA or GRDN?

Do analysts prefer SRTA or GRDN?

Which has higher valuation and earnings, SRTA or GRDN?

Does the media refer more to SRTA or GRDN?

Is SRTA or GRDN more profitable?

Which has more risk & volatility, SRTA or GRDN?

Summary

How does Strata Critical Medical compare to Agilon Health?

Which has stronger earnings and valuation, AGL or SRTA?

Do analysts recommend AGL or SRTA?

Is AGL or SRTA more profitable?

Which has more risk & volatility, AGL or SRTA?

Do institutionals & insiders believe in AGL or SRTA?

Does the media prefer AGL or SRTA?

Summary

How does Strata Critical Medical compare to InnovAge?

Does the media favor SRTA or INNV?

Is SRTA or INNV more profitable?

Which has more volatility and risk, SRTA or INNV?

Do analysts rate SRTA or INNV?

Do institutionals and insiders believe in SRTA or INNV?

Which has higher earnings and valuation, SRTA or INNV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools